Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome
Elsy M. Velazquez, Soaira G. Mendoza, Ping Wang, Charles J. GlueckVolume:
46
Année:
1997
Langue:
english
DOI:
10.1016/s0026-0495(97)90066-4
Fichier:
PDF, 449 KB
english, 1997